mCRPC (Metastatic Castration-resistant Prostate Cancer) trials recruiting in Massachusetts

All mCRPC (Metastatic Castration-resistant Prostate Cancer) trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT07719361 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Massachusetts: Boston
• A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
  NCT06844383 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Massachusetts: Boston
• Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT06801236 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Massachusetts: Boston